Streetbeat News

Equity Actions

REGN

The analysis compares Regeneron Pharmaceuticals (REGN) against its competitors in the Biotechnology industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Regeneron shows potential undervaluation based on its P/E, P/B, and P/S ratios compared to industry averages. However, its ROE is below the industry average, suggesting inefficiency in using equity to generate profits. Despite this, Regeneron's EBITDA and gross profit are above the industry average, indicating strong operational performance. The company's revenue growth is significantly lower than the industry average, highlighting a challenging sales environment.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

CDW

Recent analyst ratings for CDW (NASDAQ:CDW) show a mix of bullish to indifferent views, with an updated 12-month price target average of $272.5, reflecting an 8.64% increase from the previous target. Analyst actions include both raises and lowers in ratings and price targets, indicating varied perceptions of CDW's market position. Financially, CDW faces revenue challenges with a -7.72% decline over 3 months but maintains strong profitability indicators such as a net margin of 5.9%, ROE of 15.37%, and ROA of 2.26%, despite a high debt-to-equity ratio of 2.84.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

BWA

BorgWarner's stock price increased following the announcement of stronger than anticipated Q1 financial results and an upward revision of its FY24 adjusted EPS guidance. Additionally, the company has initiated a new share repurchase program valued at up to $500 million.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 2:48 pm

LL

F9 Investments, LLC has reported an 8.8% stake in LL Flooring Holdings as of May 2, 2024, according to a 13D filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 2:45 pm

BABA

Alibaba Group Holding has seen significant options activity, with a notable transaction involving June 21 $85 call options, purchased at the ask price of $2.00 for a quantity of 250, against an open interest of 29,723. This activity comes ahead of Alibaba's earnings report, scheduled for May 14 before the market opens, with the reference stock price at $78.25.

Portfolio Pulse from Charles Gross

May 02, 2024 | 2:26 pm

NCLH

Norwegian Cruise Line (NCLH) has been analyzed by 9 analysts, showing a mix of ratings from bullish to bearish, with a current average 12-month price target of $19.89, up 3.76% from the previous target. The company's financial performance shows significant revenue growth but challenges in profitability, debt management, and below-average returns on equity and assets. Analysts' ratings and price targets have been updated, reflecting their views on the company's market dynamics and performance.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 2:01 pm

PTC

PTC (NASDAQ:PTC) has been analyzed by 5 analysts in the last three months, showing a mix of bullish and somewhat bullish ratings with no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for PTC is $207.2, marking a 1.94% increase from the previous target of $203.25. Analyst actions include adjustments to ratings and price targets, reflecting changing market conditions and company performance. PTC's financial performance shows a revenue growth rate of 18.09% as of December 31, 2023, but lags in net margin, ROE, and ROA compared to industry averages. The company's debt-to-equity ratio is higher than the industry average, indicating a higher level of financial risk.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 2:00 pm

EEFT

Euronet Worldwide (NASDAQ:EEFT) has been evaluated by 7 analysts over the last three months, showing a bullish trend with an increase in the average 12-month price target to $126.0 from $118.33. Analysts from firms like Keefe, Bruyette & Woods, Needham, Citigroup, DA Davidson, Evercore ISI Group, and Monness, Crespi, Hardt have adjusted their ratings and price targets, reflecting optimism about the company's performance. Despite a market capitalization below industry averages and a net margin below industry standards, Euronet Worldwide has shown impressive revenue growth of 10.63% and strong ROE and ROA figures, indicating effective utilization of equity capital and assets.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 2:00 pm

BWA

BorgWarner Inc. (NYSE:BWA) reported Q1 earnings with adjusted EPS of $1.03, surpassing the analyst consensus of 87 cents, and revenues of $3.595 billion, exceeding expectations of $3.509 billion. Sales grew 6% year-over-year, driven by increased demand, despite the negative impact of foreign currencies. Gross profit rose to $644 million, with a margin expansion to 17.9%. The company announced a $500 million share buyback program, adding to the existing $267 million authorization. BorgWarner raised its FY24 adjusted EPS outlook to $3.80-$4.15 and reiterated its net sales forecast of $14.4 billion to $14.9 billion. Shares surged 7.27% to $35.26.

Portfolio Pulse from Nabaparna Bhattacharya

May 02, 2024 | 1:54 pm

IAC

IAC shares are trading higher following the announcement that the stock will be included in the S&P SmallCap 600 index.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 1:31 pm